Cargando…
Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry
OBJECTIVE. This study aimed to investigate the efficacy, safety and survival of TNF-α inhibitors in patients with RA. METHODS. A total of 178 patients >18 years of age were treated with TNF-α inhibitors. A total of 74 patients were treated with infliximab, 75 with adalimumab and 29 with etanercep...
Autores principales: | Papadopoulos, Christos G, Gartzonikas, Ilias K, Pappa, Tatiani K, Markatseli, Theodora E, Migkos, Michael P, Voulgari, Paraskevi V, Drosos, Alexandros A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649942/ https://www.ncbi.nlm.nih.gov/pubmed/31431995 http://dx.doi.org/10.1093/rap/rkz007 |
Ejemplares similares
-
Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2020) -
Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis
por: Nita, Eleni, et al.
Publicado: (2021) -
Biologic Therapies and Autoimmune Phenomena
por: Drosos, Alexandros A., et al.
Publicado: (2021) -
Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019) -
The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)